Whitehawk Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $52.5M | $28.7M |
| FY2025 | — | $136.3M | $37.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $52.5M | $28.7M |
| FY2025 | — | $136.3M | $37.6M |